Nanoplasmonic biosensor: Detection and amplification of dual bio-signatures of circulating tumor DNA

Anh H. Nguyen, Sang Jun Sim

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Circulating tumor DNA (ctDNA) bearing tumor-specific mutation and methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity. Here we present a strategy for ultrasensitive detection of tumor-specific mutations (E542K and E545K) and methylation of ctDNA of PIK3CA gene based on localized surface plasmon resonance (LSPR) and the coupling plasmon mode of gold nanoparticles (AuNPs). Peptide nucleic acids (PNA) is used as a probe to capture and enrich the 69-bp PIK3CA ctDNA. The exposure of PNA-probed AuNPs to 200. fM ctDNA generates LSPR-peak shift of 4.3. nm, corresponding to the primary response. Immunogold colloids are exploited as methylation detectors and plasmon coupling based enhancement for secondary response. LSPR-peak shifted from 4.3. nm to 11.4. nm upon the immunogold colloids binding to two methylcytosines (mCpG), which is an approximately 107% increase, compared to that of the primary response. This enhancement leads to four times (~50. fM) improvement of sensitivity and because of two mCpG sites, ctDNA was detected. These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA. Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.

Original languageEnglish
Pages (from-to)443-449
Number of pages7
JournalBiosensors and Bioelectronics
Volume67
DOIs
Publication statusPublished - 2014 Sep 6

Fingerprint

Biosensing Techniques
Biosensors
Amplification
Tumors
DNA
Neoplasms
Methylation
Surface Plasmon Resonance
Surface plasmon resonance
Peptide Nucleic Acids
Mutation
Colloids
Epigenomics
Bearings (structural)
Biomarkers
Tumor Biomarkers
Gold
Nanoparticles
Genes
Detectors

Keywords

  • Circulating tumor DNA
  • Coupling gold nanoparticles
  • DNA methylation
  • Epigenetics
  • LSPR
  • PIK3CA

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

Nanoplasmonic biosensor : Detection and amplification of dual bio-signatures of circulating tumor DNA. / Nguyen, Anh H.; Sim, Sang Jun.

In: Biosensors and Bioelectronics, Vol. 67, 06.09.2014, p. 443-449.

Research output: Contribution to journalArticle

@article{d0dde9ca81f8469a84aacf36e8d8cf1f,
title = "Nanoplasmonic biosensor: Detection and amplification of dual bio-signatures of circulating tumor DNA",
abstract = "Circulating tumor DNA (ctDNA) bearing tumor-specific mutation and methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity. Here we present a strategy for ultrasensitive detection of tumor-specific mutations (E542K and E545K) and methylation of ctDNA of PIK3CA gene based on localized surface plasmon resonance (LSPR) and the coupling plasmon mode of gold nanoparticles (AuNPs). Peptide nucleic acids (PNA) is used as a probe to capture and enrich the 69-bp PIK3CA ctDNA. The exposure of PNA-probed AuNPs to 200. fM ctDNA generates LSPR-peak shift of 4.3. nm, corresponding to the primary response. Immunogold colloids are exploited as methylation detectors and plasmon coupling based enhancement for secondary response. LSPR-peak shifted from 4.3. nm to 11.4. nm upon the immunogold colloids binding to two methylcytosines (mCpG), which is an approximately 107{\%} increase, compared to that of the primary response. This enhancement leads to four times (~50. fM) improvement of sensitivity and because of two mCpG sites, ctDNA was detected. These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA. Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.",
keywords = "Circulating tumor DNA, Coupling gold nanoparticles, DNA methylation, Epigenetics, LSPR, PIK3CA",
author = "Nguyen, {Anh H.} and Sim, {Sang Jun}",
year = "2014",
month = "9",
day = "6",
doi = "10.1016/j.bios.2014.09.003",
language = "English",
volume = "67",
pages = "443--449",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Nanoplasmonic biosensor

T2 - Detection and amplification of dual bio-signatures of circulating tumor DNA

AU - Nguyen, Anh H.

AU - Sim, Sang Jun

PY - 2014/9/6

Y1 - 2014/9/6

N2 - Circulating tumor DNA (ctDNA) bearing tumor-specific mutation and methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity. Here we present a strategy for ultrasensitive detection of tumor-specific mutations (E542K and E545K) and methylation of ctDNA of PIK3CA gene based on localized surface plasmon resonance (LSPR) and the coupling plasmon mode of gold nanoparticles (AuNPs). Peptide nucleic acids (PNA) is used as a probe to capture and enrich the 69-bp PIK3CA ctDNA. The exposure of PNA-probed AuNPs to 200. fM ctDNA generates LSPR-peak shift of 4.3. nm, corresponding to the primary response. Immunogold colloids are exploited as methylation detectors and plasmon coupling based enhancement for secondary response. LSPR-peak shifted from 4.3. nm to 11.4. nm upon the immunogold colloids binding to two methylcytosines (mCpG), which is an approximately 107% increase, compared to that of the primary response. This enhancement leads to four times (~50. fM) improvement of sensitivity and because of two mCpG sites, ctDNA was detected. These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA. Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.

AB - Circulating tumor DNA (ctDNA) bearing tumor-specific mutation and methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity. Here we present a strategy for ultrasensitive detection of tumor-specific mutations (E542K and E545K) and methylation of ctDNA of PIK3CA gene based on localized surface plasmon resonance (LSPR) and the coupling plasmon mode of gold nanoparticles (AuNPs). Peptide nucleic acids (PNA) is used as a probe to capture and enrich the 69-bp PIK3CA ctDNA. The exposure of PNA-probed AuNPs to 200. fM ctDNA generates LSPR-peak shift of 4.3. nm, corresponding to the primary response. Immunogold colloids are exploited as methylation detectors and plasmon coupling based enhancement for secondary response. LSPR-peak shifted from 4.3. nm to 11.4. nm upon the immunogold colloids binding to two methylcytosines (mCpG), which is an approximately 107% increase, compared to that of the primary response. This enhancement leads to four times (~50. fM) improvement of sensitivity and because of two mCpG sites, ctDNA was detected. These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA. Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.

KW - Circulating tumor DNA

KW - Coupling gold nanoparticles

KW - DNA methylation

KW - Epigenetics

KW - LSPR

KW - PIK3CA

UR - http://www.scopus.com/inward/record.url?scp=84922262020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922262020&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2014.09.003

DO - 10.1016/j.bios.2014.09.003

M3 - Article

C2 - 25220802

AN - SCOPUS:84922262020

VL - 67

SP - 443

EP - 449

JO - Biosensors

JF - Biosensors

SN - 0956-5663

ER -